Target intelligence / Profile preview

Pathogens and microbial antigens

Molecular classification
Other
01

Overview

Pathogens and microbial antigens represent a broad category of biological agents and their constituent molecules that trigger immune responses (Alberts et al., 2002). Pathogens include bacteria, viruses, fungi, and parasites, while antigens are specific structures—often proteins or polysaccharides—recognized by the immune system (Murphy & Weaver, 2016). These entities are central to the development of infectious diseases, where they may cause direct cellular damage or elicit harmful inflammatory cascades (NIAID, 2023). Therapeutic intervention typically involves antimicrobial drugs that disrupt pathogen-specific metabolic pathways or vaccines that utilize microbial antigens to train the host immune system (WHO, 2021). A major challenge in targeting these entities is the emergence of antimicrobial resistance and the high rate of mutation in certain pathogens, which can lead to immune evasion (WHO, 2023). Furthermore, the diversity of microbial antigens necessitates the development of broad-spectrum or highly specific therapeutic strategies depending on the clinical context.

Other names
Infectious agentsMicrobesMicrobial antigensPathogen-associated molecular patternsPAMPsEpitopesExogenous antigens
02

Mechanism of action

Antimicrobial drugs target pathogens by inhibiting cell wall synthesis, protein synthesis, or nucleic acid replication, while vaccines and monoclonal antibodies target specific microbial antigens to neutralize the pathogen or prime the host immune system for clearance (Murphy & Weaver, 2016; WHO, 2021).

03

Biological functions

Immune responsePathogenesisInfectionOther
04

Disease associations

InfectionInflammationSepsisOther
05

Safety considerations

Antimicrobial resistance (AMR)Microbiome dysbiosisCytokine release syndromeAnaphylaxisAntigenic drift and shift
06

Interacting drugs

Penicillin G

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)ProcalcitoninPathogen-specific nucleic acid amplification test (NAAT)Antibody serology (IgG/IgM)

Beyond the preview

Go deeper on Pathogens and microbial antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogens and microbial antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call